Literature DB >> 4348475

Comparative trial of P1496, a new non-steroidal oestrogen analogue.

W H Utian.   

Abstract

The results are reported of a preliminary trial of P1496, a new non-steroidal oestrogen analogue, compared with a conjugated equine oestrogen and a placebo. The oestrogenicity of both substances was well substantiated by vaginal epithelial maturation indices. P1496 was superior to conjugated equine oestrogen in producing a significant reduction of plasma calcium levels and a possible reduction in serum cholesterol. Conjugated oestrogen caused slightly more nausea than P1496 but there were no notable side effects from either drug. P1496 is considered to be at least as effective an oestrogenic substance as conjugated oestrogen and worthy of further therapeutic evaluation.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4348475      PMCID: PMC1589861          DOI: 10.1136/bmj.1.5853.579

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  6 in total

1.  EFFECTS OF ANDROGENS, ESTROGENS AND HIGH CALCIUM INTAKES ON BONE FORMATION AND RESORPTION IN OSTEOPOROSIS.

Authors:  F W LAFFERTY; G E SPENCER; O H PEARSON
Journal:  Am J Med       Date:  1964-04       Impact factor: 4.965

2.  Postmenopausal osteoporosis: a disturbance in osteoclasia.

Authors:  H M FROST
Journal:  J Am Geriatr Soc       Date:  1961-12       Impact factor: 5.562

3.  Thyroxine-binding by sera of pregnant women.

Authors:  J T DOWLING; N FREINKEL; S H INGBAR
Journal:  J Clin Endocrinol Metab       Date:  1956-02       Impact factor: 5.958

4.  Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices.

Authors:  H S KUPPERMAN; M H BLATT; H WIESBADER; W FILLER
Journal:  J Clin Endocrinol Metab       Date:  1953-06       Impact factor: 5.958

5.  Oral contraceptives and thromboembolic disease. II. Estrogen content of oral contraceptives.

Authors:  V A Drill; D W Calhoun
Journal:  JAMA       Date:  1972-01-31       Impact factor: 56.272

6.  Metabolic, hormonal, and vascular changes after synthetic oestrogen therapy in oophorectomized women.

Authors:  I MacGillivray; S Gow
Journal:  Br Med J       Date:  1971-04-10
  6 in total
  6 in total

1.  Histochemical and ultrastructural modifications of mice endometrium, vagina and pituitary following zeranol treatment.

Authors:  G R Azzali
Journal:  Experientia       Date:  1977-12-15

Review 2.  Mycotoxins.

Authors:  J W Bennett; M Klich
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

3.  The mycoestrogen zearalenone induces CYP3A through activation of the pregnane X receptor.

Authors:  Xunshan Ding; Kristin Lichti; Jeff L Staudinger
Journal:  Toxicol Sci       Date:  2006-03-17       Impact factor: 4.849

4.  Occupational exposure to zeranol, an animal growth promoter.

Authors:  T C Aw; A B Smith; R L Stephenson; C J Glueck
Journal:  Br J Ind Med       Date:  1989-05

5.  Radioimmunoassay for zearalenone and zearalanol in human serum: production, properties, and use of porcine antibodies.

Authors:  D Thouvenot; R F Morfin
Journal:  Appl Environ Microbiol       Date:  1983-01       Impact factor: 4.792

6.  Nematicidal resorcylides from the aquatic fungus Caryospora callicarpa YMF1.01026.

Authors:  Jinyan Dong; Yanhui Zhu; Hongchuan Song; Ru Li; Hongping He; Haiyang Liu; Rong Huang; Yongping Zhou; Le Wang; Yi Cao; Keqin Zhang
Journal:  J Chem Ecol       Date:  2007-03-29       Impact factor: 2.793

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.